{"DataElement":{"publicId":"7038787","version":"1","preferredName":"Primary Gleason Pattern Finding Category","preferredDefinition":"The category representing the most prevalent Gleason pattern in a prostate tissue.","longName":"MIPGLSSC","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"7038691","version":"1","preferredName":"Microscopic Findings Domain Primary Gleason Pattern Finding","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to microscopic findings._The most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen. The Gleason score is defined by adding the most prevalent (primary) and second most prevalent (secondary) patterns._Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"6407670v1.0:7038689v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6407670","version":"1","preferredName":"Microscopic Findings Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to microscopic findings.","longName":"C95095","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microscopic Findings Domain","conceptCode":"C95095","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to microscopic findings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F3D377-A300-2627-E053-F662850A04B0","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7038689","version":"1","preferredName":"Primary Gleason Pattern Finding","preferredDefinition":"The most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen. The Gleason score is defined by adding the most prevalent (primary) and second most prevalent (secondary) patterns.:Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"C48603:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Gleason Pattern","conceptCode":"C48603","definition":"The most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen. The Gleason score is defined by adding the most prevalent (primary) and second most prevalent (secondary) patterns.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"964DCE6D-EDB5-0C14-E053-F662850A025A","latestVersionIndicator":"Yes","beginDate":"2019-11-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"964DCE6D-EDC6-0C14-E053-F662850A025A","latestVersionIndicator":"Yes","beginDate":"2019-11-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"KUMMEROA","dateModified":"2020-06-17","changeDescription":"Released. AK 2020-6-10; Created for CDSIC aligned NCI Standard CRFs. ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5936783","version":"1","preferredName":"Gleason Score for Prostate Cancer Category","preferredDefinition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable._A grouping of items based on some commonality or by user defined characteristics","longName":"5936783v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"Gleason Pattern 1","ValueMeaning":{"publicId":"2925235","version":"1","preferredName":"Gleason Pattern 1","longName":"2925235","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of a well circumscribed nodule of separate glands which are closely packed. There is no infiltration of the surrounding parenchyma. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 1","conceptCode":"C28085","definition":"A pattern of prostate carcinoma characterized by the presence of a well circumscribed nodule of separate glands which are closely packed. There is no infiltration of the surrounding parenchyma. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C13D-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"576E72DD-5F11-3C5F-E053-F662850A5B33","beginDate":null,"endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"ONEDATA","dateModified":"2017-08-23","deletedIndicator":"No"},{"value":"2","valueDescription":"Gleason Pattern 2","ValueMeaning":{"publicId":"2925236","version":"1","preferredName":"Gleason Pattern 2","longName":"2925236","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of glands that are more loosely arranged and less uniform compared to Gleason pattern 1. Minimal invasion of the surrounding parenchyma may be present. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 2","conceptCode":"C28086","definition":"A pattern of prostate carcinoma characterized by the presence of glands that are more loosely arranged and less uniform compared to Gleason pattern 1. Minimal invasion of the surrounding parenchyma may be present. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C15F-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"576E72DD-5F1B-3C5F-E053-F662850A5B33","beginDate":null,"endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"ONEDATA","dateModified":"2017-08-23","deletedIndicator":"No"},{"value":"3","valueDescription":"Gleason Pattern 3","ValueMeaning":{"publicId":"2925237","version":"1","preferredName":"Gleason Pattern 3","longName":"2925237","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of glands that are infiltrative and vary in size and shape. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 3","conceptCode":"C28087","definition":"A pattern of prostate carcinoma characterized by the presence of glands that are infiltrative and vary in size and shape. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C181-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"576E72DD-5F25-3C5F-E053-F662850A5B33","beginDate":null,"endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"ONEDATA","dateModified":"2017-08-23","deletedIndicator":"No"},{"value":"4","valueDescription":"Gleason Pattern 4","ValueMeaning":{"publicId":"2925238","version":"1","preferredName":"Gleason Pattern 4","longName":"2925238","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of fused, cribriform, or poorly defined glands. There is partial loss of normal epithelial polarity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 4","conceptCode":"C28088","definition":"A pattern of prostate carcinoma characterized by the presence of fused, cribriform, or poorly defined glands. There is partial loss of normal epithelial polarity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C1A3-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"576E72DD-5F2F-3C5F-E053-F662850A5B33","beginDate":null,"endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"ONEDATA","dateModified":"2017-08-23","deletedIndicator":"No"},{"value":"5","valueDescription":"Gleason Pattern 5","ValueMeaning":{"publicId":"2925239","version":"1","preferredName":"Gleason Pattern 5","longName":"2925239","preferredDefinition":"A pattern of prostate carcinoma characterized by almost complete loss of epithelial polarity and luminal differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 5","conceptCode":"C28089","definition":"A pattern of prostate carcinoma characterized by almost complete loss of epithelial polarity and luminal differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C1C5-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"576E72DD-5F39-3C5F-E053-F662850A5B33","beginDate":null,"endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"ONEDATA","dateModified":"2017-08-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5936782","version":"1","preferredName":"Gleason Score for Prostate Cancer Category","preferredDefinition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C28084:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score for Prostate Cancer","conceptCode":"C28084","definition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"576E72DD-5EE7-3C5F-E053-F662850A5B33","latestVersionIndicator":"Yes","beginDate":"2017-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"ONEDATA","dateModified":"2017-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"576E72DD-5EF8-3C5F-E053-F662850A5B33","latestVersionIndicator":"Yes","beginDate":"2017-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"TAYLORT","dateModified":"2017-08-23","changeDescription":"8/23/17 tt new VD due to data type, added CSI and released per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6921971","version":"1","longName":"CDISC Aligned Collection CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"7318336","version":"1","longName":"Gross Pathology - CDISC Aligned","context":"NCI Standards"},{"publicId":"7318344","version":"1","longName":"Pathology - CDISC Aligned","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Primary Gleason grade","type":"Preferred Question Text","description":"Primary Gleason grade","url":null,"context":"NCI Standards"},{"name":"CDISC Aligned NCI Standard Equivalent CDE","type":"CDISC Note","description":"This data element is to be used for CDISC aligned data collection in place of CDE 5936800 from the original NCI Standard CRF Template.","url":null,"context":"NCI Standards"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"9653B769-BC67-0C09-E053-F662850AF2D7","latestVersionIndicator":"Yes","beginDate":"2019-11-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"GDEEN","dateModified":"2023-02-13","changeDescription":"Released. AK 2020-6-17; Created for CDSIC aligned NCI Standard CRFs. ghd","administrativeNotes":"02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}